Shares of Acadia Pharmaceuticals plunged more than 15% in early trade on Monday after the biopharmaceutical company received a Complete Response Letter (CRL) …
Acadia Pharmaceuticals Inc. (ACAD) has announced that it has filed a supplemental New Drug Application (sNDA) to the U.
Has Wall Street gone a bit overboard punishing ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)?
Cowen analyst Ritu Baral has recently attended a meeting with ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) management to discuss the maturing Nuplazid launch in PDP as well as …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares are shooting up almost 17% with investors clearly paying keen attention to the biotech firm’s Parkinson’s Disease Psychosis …
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced its unaudited financial results for the second quarter ended June 30, 2017.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Endo International plc – Ordinary Shares (NASDAQ:ENDP) each beat expectations on Tuesday as …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced its unaudited financial results for the first quarter ended March 31, 2017.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has Canaccord worried after releasing 2017 financial guidance yesterday morning that came up short of already subdued expectations. …
